delolimogene mupadenorepvec

AXP000007.2 · Oncolytic virus

Platform
adenovirus (Ad5/35 chimera)
Originator
Lokon Pharma
Sponsor
Lokon Pharma

Names

NameTypeSource
delolimogene mupadenorepvecpreferred name, INNcurator, ncit
LOAd703codencit
Oncolytic Adenovirus LOAd703synonymncit

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5/35 chimera
Replication
conditionally replicating
Modifications
Ad5 genome with Ad35 fiber; Delta-24 E1A
Transgenes
CD40LG, TNFSF9
Route
intratumoral
Source
evidence

Cross-references

NCI Thesaurus
C148462
Wikidata
Q140775700
FDA UNII
3ZQ57V6YWZ

Approvals

No regulatory approval recorded.

Clinical trials (4)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04123470A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant MelanomaCompletedPhase 1/22020-01-282023-07-3024Malignant Melanoma
NCT03555149A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)TerminatedPhase 1/22018-09-272022-09-2696Colorectal Cancer
NCT03225989Trial Investigating an Immunostimulatory Oncolytic Adenovirus for CancerCompletedPhase 1/22018-03-012023-08-2247Biliary Carcinoma; Colorectal Cancer; Ovarian Cancer; Pancreatic Adenocarcinoma
NCT02705196LOAd703 Oncolytic Virus Therapy for Pancreatic CancerCompletedPhase 1/22016-112025-11-1551Pancreatic Cancer

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 41698954LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.Nature communications2026cited by trial NCT04123470
PMID 41888981Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients.Biomarker research2026cited by trial NCT04123470
PMID 42053989Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial.Clinical cancer research : an official journal of the American Association for Cancer Research2026name in title: LOAd703
PMID 38547893LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.The Lancet. Oncology2024cited by trial NCT02705196

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41808784Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancer.Immuno-oncology technology2026name in title: LOAd703
PMID 42951313Immunostimulatory gene therapy with chemotherapy remodels pancreatic tumors and induces immune signatures associated with prolonged survival.Journal for immunotherapy of cancer2026name in abstract: LOAd703
PMID 40337771LOAd703 and chemotherapy combination in pancreatic cancer: insights from the LOKON001 study.Translational gastroenterology and hepatology2025name in title: LOAd703
PMID 33666760Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.Cancer immunology, immunotherapy : CII2021name in abstract: delolimogene mupadenorepvec
PMID 32355275Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.Cancer gene therapy2020name in abstract: LOAd703
PMID 28536305Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus.Clinical cancer research : an official journal of the American Association for Cancer Research2017name in abstract: LOAd703

Notes

Transgenes are trimerized membrane-bound CD40L and 4-1BBL, per the NCIt synonym; HGNC symbols assigned by the curator. Transgenes moved from targets to virus.tsv (spec 0.2).

How to cite

delolimogene mupadenorepvec (AXP000007.2). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000007.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.